Celgene (CELG) - 127.19 Buy Point
Chart courtesy of StockCharts.com
Sign in to check Buying Range, Stop-Loss, and Profit Targets. Don't have an account? Sign up for FREE — it only takes 30 seconds.

Celgene (CELG) – 127.19 Buy Point

March 6, 2017
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide.

StockFollowing.com is an informational and educational financial website, not a registered investment advisor. StockFollowing.com does not guarantee results. All information provided on this website is general in nature and is not tailored to your individual investment objectives, strategies, or needs, or relate to any specific investments. Information and services provided herein are not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable. However, no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. By using this website, you agree to the Terms of Use and Privacy Policy, which may change at any time.

Leave a Reply